Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

被引：12

作者：

Cakmak-Goeruer, Nese ^{[1
,2
,3
,4
,5
]}

Radke, Josefine ^{[3
,4
,5
,6
,7
,8
]}

Rhein, Simone ^{[2
,3
,4
,5
]}

Schumann, Elisa ^{[3
,4
,5
,6
,7
,8
]}

Willimsky, Gerald ^{[3
,4
,5
,7
,8
,9
,10
]}

Heppner, Frank L. ^{[3
,4
,5
,6
,7
,8
,11
]}

Blankenstein, Thomas ^{[1
,3
,4
,5
]}

Pezzutto, Antonio ^{[1
,2
,3
,4
,5
]}

机构：

[1] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany

[2] Charite, Berlin, Germany

[3] Free Univ Berlin, Berlin, Germany

[4] Humboldt Univ, Berlin, Germany

[5] Berlin Inst Hlth, Berlin, Germany

[6] Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany

[7] German Canc Consortium DKTK, Heidelberg, Germany

[8] Partner Site Berlin, Berlin, Germany

[9] Charite, Inst Immunol, Berlin, Germany

[10] German Canc Res Ctr, Heidelberg, Germany

[11] German Ctr Neurodegenerat Dis DZNE, Berlin, Germany

来源：

LEUKEMIA | 2019年 / 33卷 / 04期

关键词：

ACUTE MYELOID-LEUKEMIA; ANTIGEN; GENE;

D O I：

10.1038/s41375-018-0330-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1039 / 1043

页数：5

共 15 条

[1] Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia [J].

Chen, L. ;

Mao, H. ;

Zhang, J. ;

Chu, J. ;

Devine, S. ;

Caligiuri, M. A. ;

Yu, J. .

LEUKEMIA, 2017, 31 (08) :1830-1834

[2]

Chien CD, 2016, AM SOC HEMATOL, V128, P1072

[3]

DELAPEYRIERE O, 1995, DIFFERENTIATION, V58, P351, DOI 10.1007/s002580050094

[4] Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells [J].

Gill, Saar ;

Tasian, Sarah K. ;

Ruella, Marco ;

Shestova, Olga ;

Li, Yong ;

Porter, David L. ;

Carroll, Martin ;

Danet-Desnoyers, Gwenn ;

Scholler, John ;

Grupp, Stephan A. ;

June, Carl H. ;

Kalos, Michael .

BLOOD, 2014, 123 (15) :2343-2354

[5] CAR T-cells targeting FLT3 have potent activity against FLT3-ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib [J].

Jetani, Hardikkumar ;

Garcia-Cadenas, Irene ;

Nerreter, Thomas ;

Thomas, Simone ;

Rydzek, Julian ;

Briones Meijide, Javier ;

Bonig, Halvard ;

Herr, Wolfgang ;

Sierra, Jordi ;

Einsele, Hermann ;

Hudecek, Michael .

LEUKEMIA, 2018, 32 (05) :1168-1179

[6] CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia [J].

Kenderian, S. S. ;

Ruella, M. ;

Shestova, O. ;

Klichinsky, M. ;

Aikawa, V. ;

Morrissette, J. J. D. ;

Scholler, J. ;

Song, D. ;

Porter, D. L. ;

Carroll, M. ;

June, C. H. ;

Gill, S. .

LEUKEMIA, 2015, 29 (08) :1637-1647

[7] Transgenic mice with a diverse human T cell antigen receptor repertoire [J].

Li, Liang-Ping ;

Lampert, J. Christoph ;

Chen, Xiaojing ;

Leitao, Catarina ;

Popovic, Jelena ;

Mueller, Werner ;

Blankenstein, Thomas .

NATURE MEDICINE, 2010, 16 (09) :1029-U127

[8] TARGETED DISRUPTION OF THE FLK2/FLT3 GENE LEADS TO DEFICIENCIES IN PRIMITIVE HEMATOPOIETIC PROGENITORS [J].

MACKAREHTSCHIAN, K ;

HARDIN, JD ;

MOORE, KA ;

BOAST, S ;

GOFF, SP ;

LEMISCHKA, IR .

IMMUNITY, 1995, 3 (01) :147-161

[9] T-cell triggering thresholds are modulated by the number of antigen within individual T-cell receptor clusters [J].

Manza, Boryana N. ;

Jackson, Bryan L. ;

Petit, Rebecca S. ;

Dustin, Michael L. ;

Groves, Jay .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (22) :9089-9094

[10] Cancer regression in patients after transfer of genetically engineered lymphocytes [J].

Morgan, Richard A. ;

Dudley, Mark E. ;

Wunderlich, John R. ;

Hughes, Marybeth S. ;

Yang, James C. ;

Sherry, Richard M. ;

Royal, Richard E. ;

Topalian, Suzanne L. ;

Kammula, Udai S. ;

Restifo, Nicholas P. ;

Zheng, Zhili ;

Nahvi, Azam ;

de Vries, Christiaan R. ;

Rogers-Freezer, Linda J. ;

Mavroukakis, Sharon A. ;

Rosenberg, Steven A. .

SCIENCE, 2006, 314 (5796) :126-129

← 1 2 →